Companies similar to WASHINGTON UNIVERSITY IN ST. LOUIS
Sign up to Download

1-30 of 7,103,418 results

  • singularimmune.com
  • 3
Singular Immune's platform allows for the creation of iCAR and iHAR with recombinant fusion protein. These technologies allow for the modification of immune cells and stem cells within the patient's body. The iCAR technology focuses on treating..
Relevance: 18.189556
  • www.imubiosciences.com
  • 10
IMU was founded on the belief that deep immunophenotyping at population level scale powered by machine learning could unlock the power of the immune system to help develop the next generation of immune medicines. We believe that in the future, no..
Relevance: 18.163189
  • clearbtherapeutics.com
  • 1
  • 11
At ClearB, we are working to develop immunotherapies which harness the bodies' natural immune system to result in a functional cure for chronic hepatitis B (CHB)... ClearB is working to develop therapeutic vaccines designed to redirect patients'..
Relevance: 18.152197
  • www.mestagtherapeutics.com
  • 2
  • 22
Mestag is an immunotherapy company harnessing new insights into fibroblast-immune cell interactions to develop innovative treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are advancing a..
Relevance: 17.935093
  • maverslab.wustl.edu
  • 2
  • 2
  • 8
We aim to elucidate the biological mechanisms underlying immune tolerance in HSCT and develop approaches to enhance regulatory immune cells for GVHD prevention and treatment. Our goal is to use a bench-to-bedside approach to develop a cellular..
Relevance: 17.595749
  • www.amorlab.org
  • 2
  • 2
  • 2
Our lab studies cellular senescence. Senescence is a stress response program that is triggered in damaged cells and leads to their elimination by the immune system. If uncleared, the accumulation of senescent cells generates a chronic pro-..
Relevance: 17.512007
  • www.neuronity.net
  • 1
Neuronity is a biotech startup company developing First-in-Class immune therapy for age-related neurodegenerative diseases... Our team of scientists develop innovative therapies to boost healthy immune cells in aged nervous system and prevent the..
Relevance: 17.294254
  • theimmuneresponsecorp.com
The Immune Response Corporation (IRC) was founded by Dr. Jonas Salk and Kevin Kimberlin to develop an AIDS immunotherapeutic and cancer immunotherapeutic products. The company conducted 18 clinical trials regarding an HIV immune therapy which was..
Relevance: 17.220764
  • immunoengineering.gatech.edu
  • 17
  • 1
  • 29
Immunoengineering is the application of engineering tools and principles to quantitatively study the immune system in health and disease and to develop new therapies or improve existing therapies by precisely controlling and modulating a patient's..
Relevance: 17.186014
  • screentx.com
  • 1
In the complex landscape of immunology, we uncover hidden opportunities by understanding the interactions between immune cells, their microenvironment, and the ECM. At Screen Therapeutics, we harness the ECM's power to revolutionize immunology..
Relevance: 17.145763
  • abalos-tx.com
  • 1
  • 1
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system's power specifically against cancer cells. Through viral replication within..
Relevance: 16.926516
  • osivax.com
  • 1
  • 2
Osivax is developing a new class of universal vaccines empowering both arms of the immune system... Osivax is leveraging its oligoDOM® self-assembling nanoparticles platform technology to develop universal vaccines against constantly mutating..
Relevance: 16.89438
  • www.kruidbio.pw
  • 2
  • 3
  • 33
Kruid is a clinical-stage cancer immunotherapy company with multiple therapeutic approaches in development that have the potential to yield powerful immunotherapy combinations... Kruid is dedicated to its mission to discover, develop, and..
Relevance: 16.722757
  • ciiid.washington.edu
  • 36
  • 4
  • 171
The CIIID is working with colleagues across the local, national, and global responses to SARS-CoV-2 infection and COVID-19 disease. Our member's efforts include in-depth research and development activities to understand the virus-host interactions..
Relevance: 16.688776
  • www.bio-cancer.com
  • 1
  • 1
  • 10
To develop innovative bio-therapeutics for safe and effective treatments of multiple cancer indications and auto-immune disorders...
Relevance: 16.557386
  • astantetherapeutics.com
  • 1
  • 2
At Astante Therapeutics we develop drugs with novel mechanisms of action that are enhanced by drug efflux. Our unique drug delivery strategy co-opts drug efflux for therapeutic benefit by linking an anti-cancer immune response, from bystander immune..
Relevance: 16.50232
  • www.immei.de
  • 54
  • 3
  • 58
The Institute of Molecular Medicine and Experimental Immunology (IMMEI) was founded in 2002. It is located in the Biomedical center II on the Medical faculty on the Venusberg-Campus of the Friedrich-Wilhelms-Universität Bonn. The scientific mission..
Relevance: 16.427187
  • www.sgul.ac.uk
  • 49
  • 5
  • 68
The eLearning Unit at St George's, University of London works to support the student experience. We develop resources, do research, and participate in international collaborations and projects... By developing a better understanding of pathogen..
Relevance: 16.400864
  • therapyxinc.com
  • 1
  • 2
  • 6
Thera pyx (say "Thera-PIX") is a privately held development-stage biotechnology company committed to innovating our industry and changing the future of pharmaceuticals by engaging in the discovery and development of microparticulate immune..
Relevance: 16.29338
  • www.signalingsystems.ucla.edu
  • 6
  • 3
  • 10
We aim to develop a predictive understanding of the Signaling Systems that control immune responses. Projects focus on the stimulus-specific responses of immune sentinel macrophages, antibody responses produced by B-cells, and the impact of immune..
Relevance: 16.276361
  • www.prometheusbiosciences.com
  • 2
  • 1
  • 22
Prometheus Biosciences is a biotechnology company specializing in developing precision therapies for immune-mediated diseases using a one-of-a-kind approach... We're Prometheus Biosciences, an innovative biotechnology company performing..
Relevance: 16.251709
  • www.ys-ac.com
  • 1
  • 1
  • 4
Establishment of company was settled on 8th of October,2010 as an independent company from Y'sTherapeutics Co., Ltd., with an aim to develop the cancer therapy by a humanized monoclonal antibody against CD26 molecule(YS110) which is expressing on a..
Relevance: 16.245882
  • www.baylink-lab.com
  • 1
We employ a multidisciplinary approach to study how persistent bacterial infections develop and the molecular mechanisms by which bacteria resist clearance by our immune system...
Relevance: 16.221811
  • vitiligo.wiki
Vitiligo is an autoimmune disease. Normally, the immune system works throughout your body to fight off and defend your body from viruses, bacteria, and infection. In people with autoimmune diseases, the immune cells attack the body's own healthy..
Relevance: 16.141443
  • macauleylab.ca
  • 14
  • 28
Through interdisciplinary research, the Macauley Lab aims to better understand how glycans modulate our immune cells and develop small molecule tools and inhibitors...
Relevance: 16.060068
  • brainimmunologygliacenter.wustl.edu
  • 33
  • 47
By studying the complex relationships between the brain and the immune system, we aim to inform and develop new treatments for neurological diseases...
Relevance: 16.060068
  • www.imunigen.com
  • 1
At Imunigen, we develop innovative ingredients to improve the quality of life for people of all generations. With our expertise in immune health, we are dedicated to helping you advance the next era of nutritional solutions... We are committed to..
Relevance: 16.049036
  • lycera.com
  • 2
  • 13
Lycera is a private biopharmaceutical company that is developing novel small molecule immunomodulatory medicines for the treatment of autoimmune diseases and cancer. Based on its world-class R&D engine, Lycera is advancing clinical candidates from..
Relevance: 15.993054
  • www.apiieg.org
  • 7
The Asia Pacific Immunoglobulins in Immunology Expert Group Inc (APIIEG) was formed to develop a consensus view on the use of immunoglobulin products in immune disorders in the region. The aim of the Consensus Recommendations for the Use of..
Relevance: 15.872833
  • jabious.com
  • 1
  • 2
JA Bio is a startup bio-tech company located at Cambridge in Massachusetts. We are focusing on anti-cancer cell immune therapeutics discovery and development. Our research includes,... Based on NBRL (nbrm.org) developed immune cell therapy, JA Bio..
Relevance: 15.781733